- ¥4bn
- ¥3bn
- ¥3bn
- 45
- 32
- 29
- 25
Annual income statement for Fuva Brain, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,048 | 1,083 | 1,683 | 2,338 | 3,076 |
Cost of Revenue | |||||
Gross Profit | 545 | 572 | 746 | 902 | 1,013 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,106 | 1,258 | 1,728 | 2,280 | 3,058 |
Operating Profit | -58.9 | -175 | -45.3 | 58.7 | 17.1 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -63.9 | -171 | -47.2 | 53.2 | 29.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -68.6 | -174 | -29.4 | 31.6 | 31.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -68.6 | -174 | -29.4 | 26.8 | 27 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -68.6 | -174 | -29.4 | 26.8 | 27 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -16.3 | -24.8 | -3.8 | 8.48 | 10.4 |
Dividends per Share |